{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T12:21:06Z","timestamp":1793708466391,"version":"4.6.1"},"publisher-location":"Cham","reference-count":111,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319225418","type":"print"},{"value":"9783319225425","type":"electronic"}],"license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015]]},"DOI":"10.1007\/978-3-319-22542-5_5","type":"book-chapter","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T10:38:24Z","timestamp":1445510304000},"page":"117-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Calcitonin as Biomarker for the Medullary Thyroid Carcinoma"],"prefix":"10.1007","author":[{"given":"Yoon Ju","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Kratzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,23]]},"reference":[{"key":"5_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2010-2359","volume":"96","author":"SR Ahmed","year":"2011","unstructured":"Ahmed SR, Ball DW (2011) Clinical review: incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab 96:1237\u20131245","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1210\/jc.2008-1862","volume":"94","author":"A Algeciras-Schimnich","year":"2009","unstructured":"Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SK (2009) Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 94:861\u2013868","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR3","doi-asserted-by":"crossref","unstructured":"American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167\u20131214","DOI":"10.1089\/thy.2009.0110"},{"issue":"5","key":"5_CR4","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM198101293040505","volume":"304","author":"LA Austin","year":"1981","unstructured":"Austin LA, Heath H 3rd (1981) Calcitonin: physiology and pathophysiology. N Engl J Med 304(5):269\u2013278","journal-title":"N Engl J Med"},{"key":"5_CR5","unstructured":"Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R, Bigorgne JC (1991) Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients. Ann Endocrinol (Paris) 52:109\u2013112"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1373\/clinchem.2003.026963","volume":"50","author":"JP Basuyau","year":"2004","unstructured":"Basuyau JP, Mallet E, Leroy M, Brunelle P (2004) Reference intervals for serum calcitonin in men, women, and children. Clin Chem 50:1828\u20131830","journal-title":"Clin Chem"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/B978-012098652-1\/50137-2","volume-title":"Principles of bone biology","author":"KL Becker","year":"2002","unstructured":"Becker KL, M\u00fcller B, Nylen ES et al (2002) Calcitonin gene family of peptides. Structure, molecular biology and effects. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology, 3rd edn. Academic Press, San Diego, pp 619\u2013639","edition":"3"},{"key":"5_CR8","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"KL Becker","year":"2004","unstructured":"Becker KL, Nyl\u00e9n ES, White JC, M\u00fcller B, Snider RH Jr (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512\u20131525","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"5_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2265.1980.tb01032.x","volume":"13","author":"XY Bertagna","year":"1980","unstructured":"Bertagna XY, Bloomgarden ZT, Rabin D, Roberts LJ, Orth DN (1980) Molecular weight forms of immunoreactive calcitonin in a patient with medullary carcinoma of the thyroid: dynamic studies with calcium, pentagastrin and somatostatin. Clin Endocrinol (Oxf) 13(2):115\u2013123","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5_CR10","first-page":"267","volume":"114","author":"C Bieglmayer","year":"2002","unstructured":"Bieglmayer C, Scheuba C, Niederle B, Flores J, Vierhapper H (2002) Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr 114:267\u2013273","journal-title":"Wien Klin Wochenschr"},{"key":"5_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1515\/CCLM.2007.124","volume":"45","author":"C Bieglmayer","year":"2007","unstructured":"Bieglmayer C, Vierhapper H, Dudczak R, Niederle B (2007) Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med 45:662\u2013666","journal-title":"Clin Chem Lab Med"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/105072503768499716","volume":"13","author":"H Bihan","year":"2003","unstructured":"Bihan H, Becker KL, Snider RH, Nylen E, Vittaz L, Lauret C et al (2003) Calcitonin precursor levels in human medullary thyroid carcinoma. Thyroid 13:819\u2013822","journal-title":"Thyroid"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/clinchem\/30.4.511","volume":"30","author":"JJ Body","year":"1984","unstructured":"Body JJ, Heath H 3rd (1984) \u201cNonspecific\u201d increases in plasma immunoreactive calcitonin in healthy individuals: discrimination from medullary thyroid carcinoma by a new extraction technique. Clin Chem 30:511\u2013514","journal-title":"Clin Chem"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1600-6143.2005.00908.x","volume":"5","author":"KA Borchhardt","year":"2005","unstructured":"Borchhardt KA, H\u00f6rl WH, Sunder-Plassmann G (2005) Reversibility of secondary hypercalcitoninemia\u2019 after kidney transplantation. Am J Transplant 5:757\u2013763","journal-title":"Am J Transplant"},{"key":"5_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12020-013-0019-7","volume":"45","author":"IM Boschin","year":"2014","unstructured":"Boschin IM, Torresan F, Toniato A, Zane M, Ide EC, Pennelli G et al (2014) Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45:448\u2013453","journal-title":"Endocrine"},{"key":"5_CR16","first-page":"1250","volume-title":"Williams textbook of endocrinology","author":"FR Bringhurst","year":"2011","unstructured":"Bringhurst FR, Demay MB, Kronenberg HM (2011) Hormones and disorders of mineral metabolism. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology. Elsevier Saunders, Philadelphia, pp 1250\u20131252"},{"key":"5_CR17","first-page":"421","volume":"110","author":"E Bucht","year":"1985","unstructured":"Bucht E, T\u00f8rring O, Sj\u00f6berg HE (1985) Gel chromatography of immunoextracted plasma calcitonin in response to the calcium clamp in healthy males. Acta Endocrinol (Copenh) 110:421\u2013428","journal-title":"Acta Endocrinol (Copenh)"},{"key":"5_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000363055","volume":"3","author":"CP Camacho","year":"2014","unstructured":"Camacho CP, Lindsey SC, Kasamatsu TS, Machado AL, Martins JR, Biscolla RP et al (2014) Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases. Eur Thyroid J 3:117\u2013124","journal-title":"Eur Thyroid J"},{"key":"5_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0169-6009(92)90897-M","volume":"16","author":"AD Care","year":"1992","unstructured":"Care AD (1992) The regulation of the secretion of calcitonin. Bone Miner 16:182\u2013185","journal-title":"Bone Miner"},{"key":"5_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/jcem-57-4-819","volume":"57","author":"TJ Chambers","year":"1983","unstructured":"Chambers TJ, Moore A (1983) The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab 57:819\u2013824","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR21","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/endo-116-1-234","volume":"116","author":"TJ Chambers","year":"1985","unstructured":"Chambers TJ, McSheehy PM, Thomson BM, Fuller K (1985) The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116:234\u2013239","journal-title":"Endocrinology"},{"key":"5_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1210\/jc.2010-0162","volume":"96","author":"G Chambon","year":"2011","unstructured":"Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM et al (2011) The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 96:75\u201381","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1586\/erm.11.26","volume":"11","author":"T Chan","year":"2011","unstructured":"Chan T, Gu F (2011) Early diagnosis of sepsis using serum biomarkers. Expert Rev Mol Diagn 11:487\u2013496","journal-title":"Expert Rev Mol Diagn"},{"key":"5_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","volume":"85","author":"R Cohen","year":"2000","unstructured":"Cohen R, Campos JM, Sala\u00fcn C, Heshmati HM, Kraimps JL, Proye C et al (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d\u2019Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919\u2013922","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jc.2011-2033","volume":"97","author":"C Colombo","year":"2012","unstructured":"Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L et al (2012) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97:905\u2013913","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR26","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1210\/endo-70-5-638","volume":"70","author":"DH Copp","year":"1962","unstructured":"Copp DH, Cameron EC, Cheney BA, Davidson AG, Henze KG (1962) Evidence for calcitonin-a new hormone from the parathyroid that lowers blood calcium. Endocrinology 70:638\u2013649","journal-title":"Endocrinology"},{"key":"5_CR27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/jc.2006-1590","volume":"92","author":"G Costante","year":"2007","unstructured":"Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S et al (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92:450\u2013455","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ncpendmet1023","volume":"5","author":"G Costante","year":"2009","unstructured":"Costante G, Durante C, Francis Z, Schlumberger M, Filetti S (2009) Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab 5:35\u201344","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"5_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1210\/endo-81-3-610","volume":"81","author":"CW Cooper","year":"1967","unstructured":"Cooper CW, Hirsch PF, Toverud SU, Munson PL (1967) An improved method for the biological assay of thyrocalcitonin. Endocrinology 81:610\u2013616","journal-title":"Endocrinology"},{"key":"5_CR30","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1089\/thy.2010.0297","volume":"21","author":"GH Daniels","year":"2011","unstructured":"Daniels GH (2011) Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada. Thyroid 21:1199\u20131207","journal-title":"Thyroid"},{"key":"5_CR31","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jbmr.1869","volume":"28","author":"RA Davey","year":"2013","unstructured":"Davey RA, Findlay DM (2013) Calcitonin: physiology or fantasy? J Bone Miner Res 28:973\u2013979","journal-title":"J Bone Miner Res"},{"key":"5_CR32","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/0026-0495(71)90037-0","volume":"20","author":"LJ Deftos","year":"1971","unstructured":"Deftos LJ (1971) Immunoassay for human calcitonin. I. Method. Metabolism 20:1122\u20131128","journal-title":"Metabolism"},{"key":"5_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1073\/pnas.60.1.293","volume":"60","author":"LJ Deftos","year":"1968","unstructured":"Deftos LJ, Lee MR, Potts JT Jr (1968) A radioimmunoassay for thyrocalcitonin. Proc Natl Acad Sci USA 60:293\u2013299","journal-title":"Proc Natl Acad Sci USA"},{"key":"5_CR34","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1210\/jcem-40-3-409","volume":"40","author":"LJ Deftos","year":"1975","unstructured":"Deftos LJ, Roos BA, Bronzert D, Parthemore JG (1975) Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab 40:409\u2013412","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0009-8981(01)00582-4","volume":"311","author":"M d\u2019Herbomez","year":"2001","unstructured":"d\u2019Herbomez M, Leclerc L, Vantyghem MC, Fourrier F, Proye C, Wemeau JL (2001) Clinical evaluation of a new sensitive calcitonin assay: study of specificity. Clin Chim Acta 311:149\u2013155","journal-title":"Clin Chim Acta"},{"key":"5_CR36","doi-asserted-by":"crossref","unstructured":"d\u2019Herbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R, Baldet L, Carnaille B, W\u00e9meau JL, French Group GTE (Groupe des Tumeurs Endocrines) (2007) Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157:749\u2013755","DOI":"10.1530\/EJE-07-0566"},{"key":"5_CR37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1210\/jc.2003-030550","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L et al (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89:163\u2013168","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR38","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s004230050160","volume":"83","author":"M Engelbach","year":"1998","unstructured":"Engelbach M, Heerdt S, G\u00f6rges R, Kunt T, Pf\u00fctzner A, Forst T et al (1998) Is there an ectopic secretion of monomeric calcitonin in the human being? Langenbecks Arch Surg 83:456\u2013459","journal-title":"Langenbecks Arch Surg"},{"key":"5_CR39","first-page":"1890","volume":"85","author":"M Engelbach","year":"2000","unstructured":"Engelbach M, G\u00f6rges R, Forst T, Pf\u00fctzner A, Dawood R, Heerdt S et al (2000) Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements. J Clin Endocrinol Metab 85:1890\u20131894","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1210\/jcem.82.3.3797","volume":"82","author":"MF Erdogan","year":"1997","unstructured":"Erdogan MF, G\u00fcll\u00fc S, Ba\u015fkal N, Uysal AR, Kamel N, Erdo\u011fan G (1997) Omeprazole calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 82:897\u2013899","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR41","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/BF03347369","volume":"29","author":"MF Erdogan","year":"2006","unstructured":"Erdogan MF, Gursoy A, Kulaksizoglu M (2006) Long-term effects of elevated gastrin levels on calcitonin secretion. J Endocrinol Invest 29:771\u2013775","journal-title":"J Endocrinol Invest"},{"key":"5_CR42","doi-asserted-by":"crossref","unstructured":"Escalada J, Teruel JL, Pav\u00f3n I, Vila T, Navarro J, Varela C (1993) Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure. Acta Endocrinol (Copenh) 129:39\u201341","DOI":"10.1530\/acta.0.1290039"},{"key":"5_CR43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1152\/physrev.1995.75.3.429","volume":"75","author":"PA Friedmann","year":"1995","unstructured":"Friedmann PA, Gesek FA (1995) Cellular calcium transport in renal epithelia: measurement, mechanisms and regulation. Physiol Rev 75:429\u2013471","journal-title":"Physiol Rev"},{"key":"5_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7326\/0003-4819-121-3-199408010-00012","volume":"121","author":"JW Freston","year":"1994","unstructured":"Freston JW (1994) Omeprazole, hypergastrinemia, and gastric carcinoid tumors. Ann Intern Med 121:232\u2013233","journal-title":"Ann Intern Med"},{"key":"5_CR45","first-page":"49","volume":"2","author":"L Fugazzola","year":"2013","unstructured":"Fugazzola L (2013) Stimulated calcitonin cut-offs by different tests. Eur Thyroid J 2:49\u201356","journal-title":"Eur Thyroid J"},{"key":"5_CR46","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000183020","volume":"34","author":"S Garancini","year":"1983","unstructured":"Garancini S, Ballada L, Roncari G, Gastaldi L (1983) Calcitonin in chronic renal failure. Nephron 34:224\u2013227","journal-title":"Nephron"},{"key":"5_CR47","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1210\/endo.136.11.7588259","volume":"136","author":"JE Garrett","year":"1995","unstructured":"Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A et al (1995) Calcitonin-secreting cells of the thyroid express an extracellular calcitonin receptor gene. Endocrinology 136:5202\u20135211","journal-title":"Endocrinology"},{"key":"5_CR48","doi-asserted-by":"crossref","unstructured":"Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Heged\u00fcs L et al; AACE\/AME\/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules (2010) Endocr Pract 16 Suppl 1:1\u201343","DOI":"10.4158\/10024.GL"},{"key":"5_CR49","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/bjs.4875","volume":"92","author":"H Gibelin","year":"2005","unstructured":"Gibelin H, Essique D, Jones C, Levillain P, Mar\u00e9chaud R, Kraimps JL (2005) Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92:574\u2013578","journal-title":"Br J Surg"},{"key":"5_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0031-1301290","volume":"120","author":"L Giovanella","year":"2012","unstructured":"Giovanella L (2012) Serum procalcitonin and calcitonin normal values before and after calcium gluconate infusion. Exp Clin Endocrinol Diabetes 120:169\u2013170","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1172\/JCI108956","volume":"61","author":"D Goltzman","year":"1978","unstructured":"Goltzman D, Tischler AS (1978) Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture. J Clin Invest 61:449\u2013458","journal-title":"J Clin Invest"},{"key":"5_CR52","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-0029-1211997","volume":"106","author":"A Grauer","year":"1998","unstructured":"Grauer A, Raue F, Ziegler R (1998) Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes 106:353\u2013359","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5_CR53","doi-asserted-by":"crossref","unstructured":"Guesgen C, Willms A, Zwad A, Waldeck S, Wieler H, Schwab R (2013) Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary note. BMC Clin Pathol 13:27","DOI":"10.1186\/1472-6890-13-27"},{"key":"5_CR54","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/10507250150500694","volume":"11","author":"JR Hahm","year":"2001","unstructured":"Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ et al (2001) Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11:73\u201380","journal-title":"Thyroid"},{"key":"5_CR55","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1172\/JCI108865","volume":"60","author":"H Heath 3rd","year":"1977","unstructured":"Heath H 3rd, Sizemore GW (1977) Plasma calcitonin in normal man. Differences between men and women. J Clin Invest 60:1135\u20131140","journal-title":"J Clin Invest"},{"key":"5_CR56","first-page":"390","volume":"93","author":"H Heath 3rd","year":"1979","unstructured":"Heath H 3rd, Sizemore GW (1979) Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma. J Lab Clin Med 93:390\u2013401","journal-title":"J Lab Clin Med"},{"key":"5_CR57","first-page":"299","volume":"1","author":"PF Hirsch","year":"2001","unstructured":"Hirsch PF, Lester GE, Talmage RV (2001) Calcitonin, an enigmatic hormone does it have a function? J Musculoskelet Neuronal Interact 1:299\u2013305","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"5_CR500","doi-asserted-by":"crossref","unstructured":"Hirsch PF,\u00a0Voelkel EF, Munson PL\u00a0(1964) Thyrocalcitonin: Hypocalcemic hypophospatemic principle of the thyroid gland. Science 146:412\u2013413","DOI":"10.1126\/science.146.3642.412"},{"key":"5_CR58","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1056\/NEJM198708273170904","volume":"317","author":"DL Hurley","year":"1987","unstructured":"Hurley DL, Tiegs RD, Wahner HW, Heath H 3rd (1987) Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 317:537\u2013541","journal-title":"N Engl J Med"},{"key":"5_CR59","first-page":"169","volume":"21","author":"K Kaczka","year":"2012","unstructured":"Kaczka K, Mikosi\u0144ski S, Fendler W, Celnik A, Pomorski L (2012) Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Adv Clin Exp Med 21:169\u2013178","journal-title":"Adv Clin Exp Med"},{"key":"5_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2265.1979.tb01361.x","volume":"10","author":"JA Kanis","year":"1979","unstructured":"Kanis JA, Adams ND, Cecchettin M, Luizetto G, Gaspar S, Heynen G (1979) Ethanol induced secretion of calcitonin in chronic renal disease. Clin Endocrinol (Oxf) 10:155\u2013161","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5_CR61","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje.1.01867","volume":"152","author":"D Kapoor","year":"2005","unstructured":"Kapoor D, Jones TH (2005) Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152:491\u2013499","journal-title":"Eur J Endocrinol"},{"key":"5_CR62","doi-asserted-by":"crossref","unstructured":"Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M et al; German Society for Endocrinology (DGE)\u2014Thyroid Section (2004) Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112:52\u201358","DOI":"10.1055\/s-2004-815727"},{"key":"5_CR63","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/thy.2013.0121","volume":"24","author":"HK Kim","year":"2014","unstructured":"Kim HK, Bae WK, Choi YD, Shim HJ, Yoon JH, Kang HC (2014) Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer. Thyroid 24:599\u2013603","journal-title":"Thyroid"},{"key":"5_CR64","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/0003-4819-121-3-199408010-00001","volume":"121","author":"EC Klinkenberg-Knol","year":"1994","unstructured":"Klinkenberg-Knol EC, Festen HP, Jansen JB, Lamers CB, Nelis F, Snel P et al (1994) Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 121:161\u2013167","journal-title":"Ann Intern Med"},{"key":"5_CR65","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/thy.1999.9.943","volume":"9","author":"H Kotzmann","year":"1999","unstructured":"Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, S\u00f6regi G et al (1999) Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 9:943\u2013947","journal-title":"Thyroid"},{"key":"5_CR66","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1373\/clinchem.2010.151688","volume":"57","author":"J Kratzsch","year":"2011","unstructured":"Kratzsch J, Petzold A, Raue F, Reinhardt W, Br\u00f6cker-Preuss M, G\u00f6rges R et al (2011) Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57:467\u2013474","journal-title":"Clin Chem"},{"key":"5_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/jc.2005-1429","volume":"91","author":"R Leboeuf","year":"2006","unstructured":"Leboeuf R, Langlois M, Martin M, Ahnadi CE, Fink GD (2006) \u201cHook effect\u201d in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrinol Metab 91:361\u2013364","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR68","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1210\/jcem-45-3-528","volume":"45","author":"JC Lee","year":"1977","unstructured":"Lee JC, Parthemore JG, Deftos LJ (1977) Immunochemical heterogeneity of calcitonin in renal failure. J Clin Endocrinol Metab 45:528\u2013533","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR69","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1210\/jc.2007-2792","volume":"93","author":"A Machens","year":"2008","unstructured":"Machens A, Hauptmann S, Dralle H (2008) Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab 93:2234\u20132238","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR70","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1210\/jc.2014-1278","volume":"99","author":"A Machens","year":"2014","unstructured":"Machens A, Lorenz K, Dralle H (2014) Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer. J Clin Endocrinol Metab 99:2986\u20132994","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR71","first-page":"250","volume":"19","author":"ME Mart\u00ednez","year":"1983","unstructured":"Mart\u00ednez ME, Miguel JL, G\u00f3mez P, Selgas R, Salinas M, Gentil M et al (1983) Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD. Clin Nephrol 19:250\u2013253","journal-title":"Clin Nephrol"},{"key":"5_CR72","first-page":"230","volume":"38","author":"I MacIntyre","year":"1984","unstructured":"MacIntyre I, Girgis SI, Hillyard CJ (1984) Essential steps in the measurement of normal circulating levels of calcitonin. Biomed Pharmacother 38:230\u2013234","journal-title":"Biomed Pharmacother"},{"key":"5_CR73","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.178.4064.999","volume":"178","author":"SJ Marx","year":"1972","unstructured":"Marx SJ, Woodward CJ, Aurbach GD (1972) Calcitonin receptors of kidney and bone. Science 178:999\u20131001","journal-title":"Science"},{"key":"5_CR74","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/jc.2013-4088","volume":"99","author":"C Mian","year":"2014","unstructured":"Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S et al (2014) Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. J Clin Endocrinol Metab 99:1656\u20131664","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR75","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-2265.2009.03759.x","volume":"73","author":"F Milone","year":"2010","unstructured":"Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L et al (2010) Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol (Oxf) 73:85\u201388","journal-title":"Clin Endocrinol (Oxf)"},{"key":"5_CR76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1507\/endocrj1954.28.583","volume":"28","author":"S Morimoto","year":"1981","unstructured":"Morimoto S, Okada Y, Onishi T, Takai S, Miyauchi A, Lee S et al (1981) Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid. Endocrinol Jpn 28:583\u2013594","journal-title":"Endocrinol Jpn"},{"key":"5_CR77","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0009-8981(88)90365-8","volume":"174","author":"P Mott\u00e9","year":"1988","unstructured":"Mott\u00e9 P, Vauzelle P, Gardet P, Ghillani P, Caillou B, Parmentier C et al (1988) Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin Chim Acta 174:35\u201354","journal-title":"Clin Chim Acta"},{"key":"5_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000182630","volume":"31","author":"H Mulder","year":"1982","unstructured":"Mulder H, Silberbusch J, Hackeng WH, Koorevaar G, den Ottolander GJ (1982) Enhanced calcitonin release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism. Nephron. 31:123\u2013128","journal-title":"Nephron."},{"key":"5_CR79","unstructured":"Mulder H, Hackeng WH, vd Lely AJ, Siersema-Smallegange M (1990) Change of serum calcitonin in patients receiving glucocorticoids: an acute phase study. Neth J Med 36:288\u2013290"},{"key":"5_CR80","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/eje.0.1320075","volume":"132","author":"P Niccoli","year":"1995","unstructured":"Niccoli P, Brunet P, Roubicek C, Roux F, Baudin E, Lejeune PJ et al (1995) Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur J Endocrinol 132:75\u201381","journal-title":"Eur J Endocrinol"},{"key":"5_CR81","first-page":"826","volume":"78","author":"F Pacini","year":"1994","unstructured":"Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G et al (1994) Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826\u2013829","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR82","doi-asserted-by":"crossref","unstructured":"Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787\u2013803 (Erratum in: Eur J Endocrinol 155:385)","DOI":"10.1530\/eje.1.02158"},{"key":"5_CR83","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/BF03349197","volume":"29","author":"PD Papapetrou","year":"2006","unstructured":"Papapetrou PD, Polymeris A, Karga H, Vaiopoulos G (2006) Heterophilic antibodies causing falsely high serum calcitonin values. J Endocrinol Invest 29:919\u2013923","journal-title":"J Endocrinol Invest"},{"key":"5_CR84","doi-asserted-by":"publisher","first-page":"304","DOI":"10.14310\/horm.2002.1322","volume":"10","author":"A Polymeris","year":"2011","unstructured":"Polymeris A, Papapetrou PD, Papandroulaki F, Thanou S (2011) Hyperinsulinemia during oral glucose tolerance test and high normal serum cortisol are associated with increased secretion of calcitonin in normal subjects. Hormones (Athens) 10:304\u2013312","journal-title":"Hormones (Athens)"},{"key":"5_CR85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1210\/jcem-39-1-108","volume":"39","author":"JG Parthemore","year":"1974","unstructured":"Parthemore JG, Bronzert D, Roberts G, Deftos LJ (1974) A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39:108\u2013111","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR86","doi-asserted-by":"crossref","unstructured":"Pina G, Dubois S, Murat A, Berger N, Niccoli P, Peix JL et al.; Groupe de Tumeurs Endocrines (2013) Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test? Clin Endocrinol (Oxf) 78:358\u2013364. RfB4\/2014:http:\/\/www.dgkl.rfb.de\/cgi\/displayAnaStats?rv_type=TM&rvTypeForDetails=TM&year=2014&rv_num=4&analyte=all&searchType=rv_type&anaV=19). Assessed on 24 Mar 2014","DOI":"10.1111\/cen.12001"},{"key":"5_CR87","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/thy.2008.0102","volume":"19","author":"T Rink","year":"2009","unstructured":"Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Gr\u00fcnwald F (2009) Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19:327\u2013332","journal-title":"Thyroid"},{"key":"5_CR88","unstructured":"Roche cobas, calcitonin product characteristic. http:\/\/www.cobas.com\/home\/product\/clinical-and-immunochemistry-testing\/elecsys-calcitonin.html. Assessed on 24 Mar 2015"},{"key":"5_CR89","first-page":"191","volume":"48","author":"B Saller","year":"2002","unstructured":"Saller B, G\u00f6rges R, Reinhardt W, Haupt K, Janssen OE, Mann K (2002) Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. Clin Lab 48:191\u2013200","journal-title":"Clin Lab"},{"key":"5_CR90","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1067\/msy.2099.102268","volume":"126","author":"C Scheuba","year":"1999","unstructured":"Scheuba C, Kaserer K, Weinh\u00e4usl A, Pandev R, Kaider A, Passler C et al (1999) Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126:1089\u20131095","journal-title":"Surgery"},{"key":"5_CR91","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0009-8981(93)90253-Z","volume":"215","author":"S Schifter","year":"1993","unstructured":"Schifter S (1993) A new highly sensitive radioimmunoassay for human calcitonin useful for physiological studies. Clin Chim Acta 215:99\u2013109","journal-title":"Clin Chim Acta"},{"key":"5_CR92","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/0006-291X(74)91015-8","volume":"61","author":"FR Singer","year":"1974","unstructured":"Singer FR, Habener JF (1974) Multiple immunoreactive forms of calcitonin in human plasma. Biochem Biophys Res Commun 61:710\u2013716","journal-title":"Biochem Biophys Res Commun"},{"key":"5_CR93","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI108012","volume":"55","author":"GW Sizemore","year":"1975","unstructured":"Sizemore GW, Hpeath H 3rd, Larson JM (1975) Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma. J Clin Invest 55:1111\u20131118","journal-title":"J Clin Invest"},{"key":"5_CR94","doi-asserted-by":"crossref","unstructured":"Snider RH, Silva OL, Moor CF, Becker KL (1977) Clin Chim Acta. Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay 76:1\u201314","DOI":"10.1016\/0009-8981(77)90113-9"},{"key":"5_CR95","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1515\/CCLM.2004.077","volume":"42","author":"G Steinbach","year":"2004","unstructured":"Steinbach G, Rau B, Debard AL, Javourez JF, Bienvenu J, Ponzio A et al (2004) Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med 42:440\u2013449","journal-title":"Clin Chem Lab Med"},{"key":"5_CR96","first-page":"105","volume":"25","author":"J Tate","year":"2004","unstructured":"Tate J, Ward G (2004) Interferences in immunoassay. Clin Biochem Rev 25:105\u2013120","journal-title":"Clin Biochem Rev"},{"key":"5_CR97","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1210\/jc.2014-1869","volume":"99","author":"U Thiem","year":"2014","unstructured":"Thiem U, Marculescu R, Cejka D, Gessl A, Borchhardt K (2014) Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study. J Clin Endocrinol Metab 99:4704\u20134711","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR98","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1210\/jcem-57-4-749","volume":"57","author":"PH Tobler","year":"1983","unstructured":"Tobler PH, Tschopp FA, Dambacher MA, Born W, Fischer JA (1983) Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients. J Clin Endocrinol Metab 57:749\u2013754","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR99","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1590\/S1807-59322009000700015","volume":"64","author":"SP Toledo","year":"2009","unstructured":"Toledo SP, Louren\u00e7o DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE (2009) Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (Sao Paulo) 64:699\u2013706","journal-title":"Clinics (Sao Paulo)"},{"key":"5_CR100","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1515\/CCLM.2007.328","volume":"45","author":"M Tommasi","year":"2007","unstructured":"Tommasi M, Raspanti S (2007a) Hook effect in calcitonin immunoradiometric assay. Clin Chem Lab Med 45:1073\u20131074","journal-title":"Clin Chem Lab Med"},{"key":"5_CR101","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1373\/clinchem.2006.083733","volume":"53","author":"M Tommasi","year":"2007","unstructured":"Tommasi M, Raspanti S (2007b) Comparison of calcitonin determinations by polyclonal and monoclonal IRMAs. Clin Chem 53:798\u2013799","journal-title":"Clin Chem"},{"key":"5_CR102","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/00365513.2010.547214","volume":"71","author":"J Uhrova","year":"2011","unstructured":"Uhrova J, Brodska H, Vanickova Z, Benakova H, Zima T (2011) Procalcitonin interference in an immunometric calcitonin assay. Scand J Clin Lab Invest 71:157\u2013162","journal-title":"Scand J Clin Lab Invest"},{"key":"5_CR103","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF03343874","volume":"24","author":"GI Uwaifo","year":"2001","unstructured":"Uwaifo GI, Remaley AT, Stene M, Reynolds JC, Yen PM, Snider RH et al (2001) A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Invest 24:361\u2013369","journal-title":"J Endocrinol Invest"},{"key":"5_CR104","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/thy.2006.0216","volume":"17","author":"MC Vantyghem","year":"2007","unstructured":"Vantyghem MC, Danel T, Marcelli-Tourvieille S, Moriau J, Leclerc L, Cardot-Bauters C et al (2007) Calcitonin levels do not decrease with weaning in chronic alcoholism. Thyroid 17:213\u2013217","journal-title":"Thyroid"},{"key":"5_CR105","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-2002-26712","volume":"34","author":"AE Vieira","year":"2002","unstructured":"Vieira AE, Mello MP, Elias LL, Lau IF, Maciel LM, Moreira AC, Castro M (2002) Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A. Horm Metab Res 34:202\u2013206","journal-title":"Horm Metab Res"},{"key":"5_CR106","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/clinchem\/48.9.1505","volume":"48","author":"G Vitale","year":"2002","unstructured":"Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S et al (2002) Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Clin Chem 48:1505\u20131510","journal-title":"Clin Chem"},{"key":"5_CR107","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/jcem-32-1-102","volume":"32","author":"EF Voelkel","year":"1971","unstructured":"Voelkel EF, Tashjian AH Jr (1971) Measurement of thyrocalcitonin-like activity in urine of patients with medullary carcinoma. J Clin Endocrinol Metab 32:102\u2013109","journal-title":"J Clin Endocrinol Metab"},{"key":"5_CR108","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.24738","volume":"116","author":"MA Walter","year":"2010","unstructured":"Walter MA, Meier C, Radimerski T, Iten F, Kr\u00e4nzlin M, M\u00fcller-Brand J et al (2010) Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 116:31\u201340","journal-title":"Cancer"},{"key":"5_CR501","doi-asserted-by":"crossref","unstructured":"Zaidi M, Moonga BS, Abe E (2002) Calcitonin and bone formation: a knockout full of suprises. J Clin Invest 110:1769\u20131771","DOI":"10.1172\/JCI200217425"},{"key":"5_CR109","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4158\/EP12358.OR","volume":"19","author":"AA Zayed","year":"2013","unstructured":"Zayed AA, Alzubaidi M, Atallah S, Momani MS, Al-Delaimy WK (2013) Should food intake and circadian rhythm be considered when measuring serum calcitonin level? Endocr Pract 19:620\u2013626","journal-title":"Endocr Pract"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-22542-5_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T22:48:09Z","timestamp":1718146089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-22542-5_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"ISBN":["9783319225418","9783319225425"],"references-count":111,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-22542-5_5","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]},"assertion":[{"value":"23 October 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}